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ARTICLE OPEN
Qualitative study of practices and challenges when making a
diagnosis of asthma in primary care
Adeola Akindele1, Luke Daines 1, Debbie Cavers2, Hilary Pinnock1 and Aziz Sheikh1
Misdiagnosis (over-diagnosis and under-diagnosis) of asthma is common. Under-diagnosis can lead to avoidable morbidity and
mortality, while over-diagnosis exposes patients to unnecessary side effects of treatment(s) and results in unnecessary healthcare
expenditure. We explored diagnostic approaches and challenges faced by general practitioners (GPs) and practice nurses when
making a diagnosis of asthma. Fifteen healthcare professionals (10 GPs and 5 nurses) of both sexes, different ages and varying years
of experience who worked in NHS Lothian, Scotland were interviewed using in-depth, semi-structured qualitative interviews.
Transcripts were analysed using a thematic approach. Clinical judgement of the probability of asthma was fundamental in the
diagnostic process. Participants used heuristic approaches to assess the clinical probability of asthma and then decide what tests to
do, selecting peak expiratory ﬂow measurements, spirometry and/or a trial of treatment as appropriate for each patient. Challenges
in the diagnostic process included time pressures, the variable nature of asthma, overlapping clinical features of asthma with other
conditions such as respiratory viral illnesses in children and chronic obstructive pulmonary disease (COPD) in adults. To improve
diagnostic decision-making, participants suggested regular educational opportunities and better diagnostic tools. In the future,
standardising the clinical assessment made by healthcare practitioners should be supported by improved access to diagnostic
services for additional investigation(s) and clariﬁcation of diagnostic uncertainty.
npj Primary Care Respiratory Medicine           (2019) 29:27 ; https://doi.org/10.1038/s41533-019-0140-z
INTRODUCTION
Over-diagnosis and under-diagnosis of asthma are common.1–4 In
Canada, asthma was ruled out in 33% of people with doctor-
diagnosed asthma.3 Meanwhile, in the Netherlands 21% of people
were underdiagnosed by their general practitioners (GPs).4
Consequences of under-diagnosis are a lack of treatment, with
potentially avoidable morbidity. Over-diagnosis exposes patients
to unnecessary side effects of treatment(s) and contributes to
increased healthcare costs.5
In the United Kingdom (UK), asthma affects up to 5.4 million
people, causes >1000 deaths annually and accounts for an
estimated £1.1 billion in annual National Health Service (NHS)
spending.6,7 As most asthma diagnoses are made in primary care,
it is particularly important to explore the misdiagnosis of asthma
in this setting.
Asthma diagnosis is difﬁcult for several reasons. First, asthma is
a variable condition that relapses and remits, so symptoms and
signs are often not present during a routine healthcare appoint-
ment.8 Second, there is no gold-standard diagnostic test for
asthma.9 In practice, peak expiratory ﬂow measurements and
spirometry are used to demonstrate features of asthma, such as
variable airway obstruction and reversibility of airway obstruction
with bronchodilator drugs.10 However, these tests cannot always
exclude asthma as results may be normal when patients are
asymptomatic.8,10 Challenge tests with histamine or methacholine
have greater sensitivity but are often not tolerated well by
patients and are not undertaken in community settings.11,12 Third,
guideline recommendations are not always compatible with
working systems in primary care. For instance, objective testing
is not always available in the community, and even if available,
testing cannot always be done due to time pressures.10 This is
particularly relevant in the UK, given that the recent National
Institute for Health and Care Excellence (NICE) guidelines
recommend fractional exhaled nitric oxide (FeNO) and spirometry
as core tests for making a diagnosis in all patients.9 FeNO indicates
eosinophilic inﬂammation and raised FeNO levels support a
diagnosis of asthma.13 However, FeNO levels may also be elevated
in males, people with allergic rhinitis, rhinovirus infection and
following intake of nitrate-rich foods such as green vegetables,
which can lead to false positive results. In addition, FeNO levels
may be reduced in smokers and in people who have had steroid
treatment raising the possibility of false negatives. Furthermore, it
is currently unclear how best to implement FeNO in routine UK
primary care settings.14
Most previous studies on misdiagnosis of asthma have used a
quantitative approach to demonstrate the proportion of people
who are over- or under-diagnosed1–4 but have not sought to
understand why these misdiagnoses occur. Qualitative studies
enable exploration of the factors inﬂuencing diagnostic decision-
making and the challenges involved.15 Therefore, the aim of this
study was to explore the experiences and perspectives of doctors
and nurses when making a diagnosis of asthma in primary care.
Speciﬁcally, our objectives were to:
a. Determine the diagnostic process used by each clinician and
understand which elements from a patient’s history, tests
and clinical record are most valued.
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b. Identify the challenges faced by clinicians when making a
diagnosis.
c. Explore sources of asthma misdiagnosis and ideas to help
improve the accuracy of diagnosis of asthma in primary
care, including the use of clinical prediction tools.
RESULTS
Ten GPs and ﬁve practice nurses took part in face-to-face
interviews between February and April 2018. (Tables 1 and 2).
Interviews lasted between 25 and 40min. Five major themes were
generated from the thematic analysis: approach to diagnosis,
factors affecting the approach to diagnosis, challenges affecting
diagnoses, misdiagnosis of asthma, and suggestions for and
opinions on potential future approaches to asthma diagnosis.
The diagnostic process
Participants used the probability of asthma determined from the
clinical history to guide their diagnostic approach. Patients with a
high probability of asthma were those with wheeze, family history
of asthma, personal or family history of atopy, nocturnal
symptoms and/or exertional symptoms.
So the things that would make me think “yes, this is more
likely to be asthma” is themselves having had a history of
being a viral wheezer as a child, having atopy in the family,
having eczema in the family or themselves, allergies to pets
and things. And a typical history of asthma, as in worsening
with certain things, worsening with eczema, worsening with
cold air, for example. Not just wheezy all the time. GP 7
When patients’ symptoms suggested a high probability of
asthma, most participants carried out further, immediately
available, testing e.g. with a peak ﬂow meter.
If I think it’s a very convincing clinical picture […]. Then if I
think their spot peak ﬂow is reduced, for example, and
there’s no intercurrent infection to explain it, if I [think it is]
high probability I would be fairly conﬁdent about just
empirically starting some treatment and then monitoring…
essentially a trial of treatment. GP 6
The tests available to participants in their practices were peak
ﬂow meters and spirometry. Most participants used peak ﬂow
meters as the ﬁrst line of investigation though factors including
age and compliance inﬂuenced which test was used.
In younger children, participants recognised that objective
testing was difﬁcult, though sometimes used peak ﬂow measure-
ments to arrive at a diagnosis.
If they’re able to, kids-wise, I’d probably go down the serial
peak ﬂow route before I would think about spirometry. […]
Because really, like I say, even trying to get them to do a
proper peak ﬂow can be difﬁcult. Nurse 2
Meanwhile in adults, GPs had greater conﬁdence to request
spirometry compared to nurses, if there was diagnostic uncer-
tainty or if patients were unlikely to be compliant with peak ﬂow
measurements.
So if it’s someone that can do a simple peak ﬂow meter, I
would do that in the ﬁrst instance. […] Whereas if they’re
probably not compliant or they’re too young or you’re
worried that there might be… they’re smokers, you know,
it’s not kind of classic asthma symptoms, then usually
they’re referred to spirometry. GP 10.
Six out of the ten practices involved in this study had access to
in-house spirometry. However, some GPs preferred hospital
testing to in-house spirometry because they were more conﬁdent
with the results and they had concerns about adding to workload
pressures for their staff.
We do have spirometry machines here but we’d still tend to
get them done at the hospital. […] we would trust the
results more. And also time; our nurses are fully booked […]
the more things like that we do here, it just becomes
Table 1. Participant characteristics
Characteristics Participants
(n= 15)
Sex
Female 11
Male 4
Role
GP 10
Nurse 5
Age (years)
<40 8
41–50 3
51–60 3
>60 1
Role in practice
Partner 2
Salaried 5
Locum 2
Out-of-hours 1
Practice nurse 4
Nurse practitioner 1
Interest in asthma
Diploma in asthma 5 (all nurses)
Asthma lead 1 (GP partner)
Years since qualiﬁcation,
median (range)
13 (0.5–37)
Table 2. Practice characteristics
Practices (n= 10) n
Practice list sizea
<5000 1
5000–10,000 7
>10 000 2
Practice Index of multiple deprivationb
1–5 (more deprived) 8
6–10 (less deprived) 2
aISD Scotland: https://www.isdscotland.org/Health-Topics/General-
Practice/Workforce-and-Practice-Populations/_docs/
Practice_ContactDetails_Jan2018_ﬁnal.xlsx?14:33:27
bScottish Government: http://www.gov.scot/Resource/0050/00505244.xlsx
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unmanageable. Like we don’t have enough nurses’ slots for
dressings or other stuff. GP 5
Participants used a trial of treatment as a diagnostic approach
at different stages of the diagnostic process. Some participants
used the trial of treatment to conﬁrm the diagnosis when
spirometry and peak ﬂow measurements were normal but the
clinical probability of asthma was high.
Yeah, so if I felt they were pointing more towards asthma
but their spirometry was still normal, and say their chest X-
ray was normal as well, then I would consider a trial of
treatment. GP 8
Meanwhile, some participants used a trial of treatment without
objective testing as the main diagnostic tool, if the clinical
probability of asthma was high. They explained that this
approach was based on current British Thoracic Society/Scottish
Intercollegiate Guidelines Network (BTS/SIGN) guideline
recommendations.16
Certainly the diagnosis part has all changed because we can
now look at the probability and go directly into trial of
treatment rather than saying “right, well, we’ll do peak ﬂow
diary on everyone”. Nurse 1
None of the participants in the study had FeNO available in their
practice. Participants understood the potential beneﬁts of FeNO
testing, though most were worried about the cost of introducing
FeNO into primary care.
I do feel it would be a step forward for us being more
proactive and positive with tests if it was available but I
suppose it’s ﬁnances to supply the FeNO. Nurse 4
Chest X-ray and full blood count including eosinophils were
other non-routine tests used by participants to conﬁrm or refute
asthma.
Challenges of asthma diagnosis
Participants felt that diagnosis was difﬁcult if patients were
asymptomatic at the time of testing, as objective tests were often
normal.
So quite often if they’re not symptomatic when they come
here so you’re not going to get any change in reversibility.
So it’s not always as straightforward as that – sometimes it
is but sometimes it’s not. Nurse 4
Nurses also felt that having asymptomatic intervals made it
challenging to arrive at a ﬁnal diagnosis, as patients often failed to
come for follow-up appointments.
Sometimes you’ll send them away with serial peak ﬂow
monitors to do readings and they don’t always appear back.
Because I think maybe sometimes if you’re looking at their
symptoms, maybe their symptoms have improved and
they’ve not bothered doing it and they just don’t bother
coming back. Nurse 2
Participants found it difﬁcult to differentiate between asthma
and other closely related conditions, especially at the extremes of
age. In children, participants found it difﬁcult to differentiate
between multiple presentations of viral-induced wheeze and
asthma.
Viral-induced wheeze in asthma [is difﬁcult]. Because you
could genuinely have, I think, a little bit of wheeze with a
virus that’s not asthma and you can genuinely have asthma
that is made worse by a virus. GP 9
At the other extreme, participants were especially worried that
many other conditions could cause symptoms in older people.
I mean, when you get older, anything can cause a shortness
of breath on exertion, can’t it? It could be cardiac, anaemia
or kind of respiratory as well. They’re much more likely to
have COPD if they’ve been smokers. Or you can get kind of
COPD and asthma kind of overlap as well. GP 2
Furthermore, in adults, participants sometimes found it difﬁcult
to differentiate exercise-induced asthma from a normal response
to exercise.
One of the things I ﬁnd difﬁcult is exercise-induced. You
know, you get a lot of people saying, “oh, I get short-of-
breath when I exercise” and when you take their history it’s
very much like “when I’m working hard I get short-of-
breath” and you think “well, that’s just exercise, that’s what
happens when you run up a hill, you get short-of-breath,
you know.” GP 7
Some participants felt that arriving at an asthma diagnosis was
difﬁcult to achieve with the time pressures in general practice.
Yeah, in a single standard appointment, which is usually
10 min, it’s fairly difﬁcult to make a deﬁnitive diagnosis. So
that’s often why I use tools and techniques, such as the
peak ﬂow diary or a trial of treatment. GP 6
Understanding misdiagnosis
Under-diagnosis was perceived to be less of a problem than over-
diagnosis. Participants felt that if people did not present, they
could not make a diagnosis.
I mean, there could be plenty of people out there who
never see their GP who might have a bit of asthma that, you
know, GPs would never know about because they never
come and they’d never report the fact they’d got exertional
symptoms. GP 2
Participants explained that, because salbutamol provides
symptomatic relief, trials of salbutamol inhalers were commonly
given to patients with respiratory symptoms pending a deﬁnite
diagnosis.
One reason for participants continuing to prescribe treatment
without a diagnosis was the fear of incorrectly labelling a patient
with asthma.
No [I don’t ﬁnd diagnosis easy], I mean, I hesitate to put on a
repeat prescription for salbutamol and I might even do it
without putting the ‘asthma’ word on it. GP3
Some participants expressed concern that one-off prescriptions
of salbutamol may become repeat prescriptions based on patient
request if there were no clear records of the basis of the initial
prescription.
So they have an acute prescription for salbutamol and then
maybe they go to another GP and say “well, I have to keep
A. Akindele et al.
3
Published in partnership with Primary Care Respiratory Society UK npj Primary Care Respiratory Medicine (2019)    27 
on getting my acute, can you put it on repeat?” And then it
almost seems like the next GP that sees them they’ll start
treating them as though they do have asthma. GP 1
Although some participants found asthma diagnoses time
consuming, other participants expressed concern that misdiagno-
sis may occur if a diagnosis was made too quickly.
And looking back, when I’m saying people aren’t asthmatic
anymore and saying ‘asthma resolved’, it’s that the doctor
just seems to have come to a quick decision. GP 5
This GP and some other participants described ‘using time as a
diagnostic tool’.
A future approach to asthma diagnosis
Participants suggested regular educational updates as a way of
improving the diagnostic accuracy of asthma in general practice.
I think GP education’s very important. […] I think having
regular CPD (Continuous Professional Development) about
that’s really important, because we get de-skilled very
quickly, and just seeing what’s there. GP 10
Other suggestions to improve the diagnosis of asthma in
primary care included having a clearer diagnostic process and
more tests.
I think the more tests we can have, the better. I think
patient education and obviously healthcare education,
because it isn’t straightforward. Obviously, they’re tools we
can all use but the more tools, the better, I feel. Nurse 4
I mean, it’s all about if there was a clear diagnostic process
which is standardised and put in everyone’s face and clearly
set out then that would be helpful. GP 4
Interestingly, one nurse suggested the use of a tool to help her
quantify the risk of asthma even before being asked about clinical
prediction tools.
Maybe if there was a kind of tool that helped bring all these
different factors… you know, like when we’re looking at
symptoms and we’re looking at their spirometries and all
that, […], just to kind of look at it all and help us think “oh,
that IS a high probability” or there is a kind of suspicion of
asthma but we’re not sure, that kind of thing. Nurse 2
Proposed clinical prediction tool
Participants were speciﬁcally asked to comment on the use of
clinical prediction tool and diagnostic hubs to improve asthma
diagnosis. All the nurses interviewed liked the idea of an
additional tool that guided their decision-making process.
Yeah. I mean, certainly, absolutely, it can take you, I
suppose, quite easily into the high probability section and
then from there you would know what to do. But obviously
it’s a clinical thing, isn’t it, as well? But no, absolutely, I think
any tool that helps you decide that there’s… because there
can be a sort of ambiguity. Nurse 1
By comparison, most GPs preferred using their clinical judge-
ment to diagnose asthma and were reluctant to use a tool that
provided the probability of asthma.
I think at the moment it’s very much gut feeling and using
time as a diagnostician and asking the patient about their
symptoms. And because it’s history-based, it’s very much
kind of you’re asking the patient preferences and the
patient’s got more autonomy. […] And I think introducing
calculators makes general practice a lot less sensitive, gut
feeling, what the patient wants and much more protocol-
driven… I think with asthma speciﬁcally, because it’s so
history-based, there’s so much on gut feeling, they’re
probably not a good thing. GP 2
There were, however, some GPs who were open to using a
prediction tool if it was validated to have a high positive predictive
value, promoted by guidelines, easy to use and self-populated
with available data from the electronic patient record system used
by GPs.
I mean, all of these tools, if they’re easy to use and simple,
can help guide our clinical judgement. Absolutely, yeah,
why not? So they have to be easily-accessible […]. I suppose
the other point is, you wouldn’t use it if it’s not validated
and no good so it has to have a high usefulness. It can be as
easy as anything but if it’s not very sensitive then there’s no
point. GP 7
Proposed diagnostic hubs
Participants were open to using diagnostic hubs as a centre for
diagnostic queries. They thought it would be helpful to provide
continuity of testing as they envisioned that the same person
might do the history and investigations.
But I can see where being in a central place for… you would
get the continuity of all the testing but it would have to be
done over a day, they would have to go back and get the
results and show them, Yeah. Nurse 1
The advantage of diagnostic hubs to provide easy access and
reduce waiting times was also mentioned.
It would deﬁnitely be useful in the ease of accessing
resources like that or the provision in terms of location and
accessibility and waiting times. If that’s easier then those
services will get used more and they may well be
helpful. GP 6
However, some participants were worried about the deskilling
of primary care practitioners if all patients with suspected asthma
were sent to a hub for diagnosis.
I suppose for us it might de-skill us slightly because then we
wouldn’t be seeing these patients very regularly and then
you wouldn’t be using… I suppose you’d still be doing your
spirometry and all these things for your COPDs but aye
(yes), it would maybe de-skill us slightly. Nurse 2
A GP suggested that sending patients to a diagnostic hub to
conﬁrm asthma would reduce GPs’ conﬁdence in the ability to
diagnose asthma.
Yeah, it does really de-skill. [..] Or actually, maybe most of it
would be lack of conﬁdence, really. But yeah, I think kind of
getting a diagnosis in a hub would deﬁnitely de-skill. And I
think asthma should be kind of bread-and-butter for
GPs. GP 2
A. Akindele et al.
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DISCUSSION
We aimed to explore the experiences and perspectives of doctors
and nurses when making a diagnosis of asthma in primary care.
Participants used heuristics to assess the clinical probability of
asthma to decide if and which of peak ﬂow measurements,
spirometry and trial of treatment would be appropriate for each
patient. Participants found asthma diagnosis difﬁcult at the
extremes of age; when features of asthma overlapped with other
conditions such as viral illnesses and chronic obstructive
pulmonary disease (COPD), especially in those too young for
tests. Under-diagnosis was due to patients’ decision to present (or
not); meanwhile, having patients on treatment without a
diagnosis contributed to over-diagnosis. Participants suggested
that regular education and better diagnostic tools would improve
asthma diagnosis in primary care.
Most participants found the use of tests to reﬁne the probability
of asthma helpful. However, some participants felt that if the
probability of asthma was high, treatment could be started
without objective testing. This approach resonates with the BTS/
SIGN guidelines, which recommends determining the initial
probability of asthma using a structured clinical assessment.16 If
the probability of asthma is high, a carefully monitored initiation
of treatment can be considered, using objective measurements of
lung function and/or a validated control questionnaire to conﬁrm
(or refute) the already high probability of asthma.16 However,
there is no evidence-based deﬁnition of ‘high probability’ leaving
clinicians with a lack of clear guidance on the predictive value of
common symptoms and items in the clinical history, the threshold
at which further tests are needed and the order in which
investigations should be performed. In order to reduce misdiag-
nosis, further research is needed to quantify probabilities and
develop tests that provide more accurate results and take little
time or resources to perform.17
The Bayesian terminology of probabilities reﬂects the recog-
nised clinical strategy for making a diagnosis.18 Most of the GP
participants were comfortable with this approach and felt
uncertain about whether clinical prediction tools would be
beneﬁcial. In comparison, other participants, including all the
nurses interviewed, were open to the advantages of a system that
guided their clinical judgement as long as it was ‘easy to use’. To
be acceptable to clinicians and adopted in routine practice, clinical
prediction tools will not only have to offer practical advice about
(available) tests and deliver an accurate probability of a diagnosis
but will also be more acceptable if they operate within current
diagnostic paradigms.19
Diagnostic overlap sometimes made asthma diagnosis difﬁcult
for participants in this study. In children, this overlap was between
viral-induced wheeze and asthma. Meanwhile, in adults, partici-
pants worried about conditions such as COPD, echoing widely
expressed views.20–22 Contemporary understanding of ‘the
asthmas’ is moving towards considering asthma as an initial
description, which is then reﬁned into phenotypes with different
disease trajectories, and underlying airway inﬂammation.23,24 The
future of asthma diagnosis (at least in resource-rich settings) may
therefore move away from the label of ‘asthma’ to delineating
phenotypes or ‘treatable traits’ requiring additional tests (such as
FeNO). However, none of the participants in this study had FeNO
available within their practice and several participants expressed
concern over the resource implications of providing FeNO. Indeed,
despite having access to spirometry, some participants referred
patients to secondary care for spirometry for reasons of resource
as well as quality.
Diagnostic hubs are a model of care that offer an alternative to
provision of respiratory investigations within the practice poten-
tially offering not only expertise but also enabling timely
introduction of new approaches to diagnosis and phenotyping.25
Evidence for these approaches will need to include clinical and
cost-effectiveness considerations to guide implementation.
Fear of incorrectly labelling patients with asthma may explain
under-diagnosis of asthma for some patients; several GPs adopted
symptomatic treatment rather than diagnostic labels due to lack
of certainty.26,27 Although avoiding labels is not unique to
asthma,27 the implications of symptomatic relief instead of a
diagnosis may delay provision of effective interventions, such as
supported self-management.28 In contrast, difﬁculty communicat-
ing uncertainty to patients may lead some clinicians to attach a
label before a diagnosis is conﬁrmed thereby risking over-
diagnosis. Some participants suggested that there was a risk that
a ‘suspected asthma’ code could become an ‘asthma’ code by
default if patients’ requests for repeat prescriptions were not
scrutinised carefully—a risk potentially exacerbated by a lack of
continuity of care. This emphasises the importance of guideline
recommendation to ‘record the basis on which the diagnosis was
made’.16,29
By using a qualitative approach, this study has provided insights
into primary care professionals’ views, experiences, frustrations
and ideas for improvement when diagnosing asthma. The
information gathered can inform healthcare providers and
policymakers, enabling them to recognise and address practical
challenges. Our participants represented a range of experience
and practice demography, but all were within NHS Lothian (and
thus had access to secondary/tertiary diagnostic services); GPs
working in rural or remote areas may have other perspectives. Our
ﬁndings may be applicable to other similar healthcare systems,
though globally, approaches to diagnosis will vary.30,31
The inﬂuence of the interviewer in qualitative studies must be
considered. A.A. conducted the interviews as a medical student.
This allowed her to ask more ‘why’ questions about decision-
making than an experienced clinician may have omitted if they
felt the answer was obvious. Nevertheless, some participants
assumed that questions were testing their knowledge. To deal
with this, questions were phrased to emphasise experience, yet
some responses might have been provided to match expectations
rather than a true reﬂection of day-to-day practice. In qualitative
studies, sample size may be considered adequate when it is
unlikely that further interviews will yield new responses.32 For
resource reasons, our study was limited to obtaining the views of
15 primary care practitioners. This was sufﬁcient to reach data
saturation with respect to the current diagnostic processes used,
but we may not have heard all views on misdiagnosis and new
approaches to asthma diagnosis.
Policy and health service concerns about misdiagnosis are
reﬂected in the perceptions of individual healthcare professionals
who perceive the diagnosis of asthma to be challenging and (in
the absence of a diagnostic test) rely on clinical assessment of
probabilities. The lack of evidence-based algorithms for achieving
a robust diagnosis, and the evolution of the concept of ‘treatable
traits’, have added to diagnostic uncertainty, which may
contribute to under- and over-diagnosis. Decision support systems
that aid clinicians to assess probabilities more accurately and
optimise the use of existing diagnostic tests may be an effective
approach to reducing misdiagnosis. The observation that practice
nurses were more inclined towards a tool that guided their clinical
judgement than GPs should be considered in the design of future
diagnostic aids. Other recommendations to improve the accuracy
of asthma diagnosis include greater provision of professional
education and improving access to investigations such as
spirometry, potentially through diagnostic hubs.
This study describes the current approach of determining the
probability of asthma based on a clinical assessment corroborated
by peak expiratory ﬂow measurements, spirometry and/or a trial
of treatment. Challenges related to time and resource pressures in
general practice and the overlapping features of asthma with
other conditions. Future models of care need to provide cost-
A. Akindele et al.
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effective access to accurate (potentially novel) tests, and institute
diagnostic services that guide clinicians through evidence-based
algorithms and that reﬂect our evolving understanding of asthma
and its phenotypes are needed.
METHODS
Design
This is a qualitative study using semi-structured interviews with UK GPs
and practice nurses in Lothian, Scotland.
Ethics
The study was reviewed by the Research and Development Committee,
Queen’s Medical Research Institute Edinburgh who approved the study
and considered that no ethical review was required for interviews with
health professionals. (Lothian project R&D no: 2017/0292)
Participant recruitment
GPs and practice nurses working in NHS Lothian, Scotland were invited to
take part in the study through local primary care networks and word of
mouth. From this group of potential participants, we selected a diverse
sub-sample; a mix of professionals based on gender, years of experience
and clinical role. Interested GPs and practice nurses were emailed the
information leaﬂet explaining the reasons for the study and potential uses
of the results obtained from the study. All participants provided written
informed consent.
Data generation
A topic guide, with prompts informed by existing literature, was used to
answer the research questions (Supplementary Table 1). Interviews were
carried out by A.A., a postgraduate medical student at The University of
Edinburgh with close support and training from L.D. and A.S. (both clinical
academics). In preparation for data collection, A.A. completed three pilot
interviews with GP colleagues, receiving feedback from the interviewee
and the research team. Regular team meetings were held throughout the
study period to review transcripts and reﬁne interview technique.
GPs and practice nurses were asked how they made a diagnosis of asthma,
the investigations available and the challenges they faced when making a
diagnosis of asthma. In addition, participants were asked about their
perspectives on asthma misdiagnosis and their suggestions for improving
the diagnosis of asthma in primary care. Participants were also asked to
comment speciﬁcally on ideas that have been suggested to improve asthma
diagnosis including a clinical prediction tool to determine the probability of
asthma during consultations and provision of diagnostic hubs that serve as a
‘one-stop shop’ for patients to receive all necessary assessments.9,25
The interviews took place in clinics and university meeting rooms. All
interviews were digitally audio-recorded and transcribed verbatim. There
were no repeat interviews. Field notes made after each interview were also
used to record relevant contextual issues, such as rapport and questions
raised.
Data analysis
Transcripts were analysed using a thematic approach as described by
Braun and Clarke.33 Initially, each transcript was studied, and sections of
text were coded. In the early stages of analysis, A.A. in discussion with L.D.,
A.S. and D.C. drew up a provisional coding framework guided by the
research questions. Codes were then aggregated into major themes and
subthemes using NVivo 11 (QSR international). Following regular discus-
sion with the research team, the coding framework was continuously
reﬁned to include new themes and subthemes identiﬁed as the transcripts
were reread in order to reﬂect the entire data set (see Supplementary
Table 2 for ﬁnal coding framework). The consolidated criteria for reporting
qualitative research (COREQ) was used to guide reporting (Supplementary
Table 3).
Reporting summary
Further information on experimental design is available in the Nature
Research Reporting Summary linked to this article.
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